Concert Pharmaceuticals building a strong portfolio of autoimmune and CNS indications
Concert Pharmaceuticals (NASDAQ: CNCE), a clinical stage biopharmaceutical Company, announced the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for patent application No. 16/098,338 related to CTP-543, its lead candidate for the treatment of alopecia areata. The patent covers pharmaceutical...
